Offer - Urjas Oil for just ₹ 1 X
Erleva 100 Mg Tablet is a prescription medicine that is available as a Tablet. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
The correct dosage of Erleva 100 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Erleva 100 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Erleva 100 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Erleva 100 Mg Tablet's effect during pregnancy is Moderate and Moderate while nursing. Further, the section on Erleva 100 Mg Tablet related warnings talks about Erleva 100 Mg Tablet's effects on the liver, heart and kidney.
Erleva 100 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Erleva 100 Mg Tablet in conditions like Liver Disease, Kidney Disease, Lung Disease. The section on Erleva 100 Mg Tablet contraindications lists all such conditions.
Drug interactions for Erleva 100 Mg Tablet have been reported in the medical literature. See below for a complete list.
You should also be aware that Erleva 100 Mg Tablet is not safe while driving, and is not addiction.
Erleva 100 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erleva 100 Mg Tablet safe for pregnant women?
Erleva may have some side effects during pregnancy. Pregnant women should discontinue the use of Erleva, and talk to their doctor, if they notice any discomfort.
Is the use of Erleva 100 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erleva. If you see any side effects, stop taking Erleva immediately and talk to your doctor. Take Erleva again, only after your doctor's advice.
What is the effect of Erleva 100 Mg Tablet on the Kidneys?
Erleva is not harmful for kidneys.
What is the effect of Erleva 100 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Erleva. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Erleva 100 Mg Tablet on the Heart?
Erleva is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Erleva 100 Mg Tablet unless your doctor advises you to do so -
Is this Erleva 100 Mg Tablet habit forming or addictive?
No, there is no any evidence that Erleva 100 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Erleva 100 Mg Tablet can make you feel drowsy.
Is it safe?
Erleva 100 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Erleva 100 Mg Tablet in mental disorders is not effective.
Interaction between Food and Erleva 100 Mg Tablet
Some foods when eaten with Erleva 100 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erleva 100 Mg Tablet
Information about the interaction of Erleva 100 Mg Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516